{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T17:35:10Z","timestamp":1781199310092,"version":"3.54.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,9,11]],"date-time":"2015-09-11T00:00:00Z","timestamp":1441929600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gastric Cancer"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1007\/s10120-015-0540-x","type":"journal-article","created":{"date-parts":[[2015,9,11]],"date-time":"2015-09-11T11:37:40Z","timestamp":1441971460000},"page":"894-901","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Excessive watering eyes in gastric cancer patients receiving S-1 chemotherapy"],"prefix":"10.1007","volume":"19","author":[{"given":"Hiroyuki","family":"Tabuse","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroya","family":"Kashiwagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Hamauchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Tsushima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Todaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoya","family":"Yokota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nozomu","family":"Machida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Fukutomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Onozawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keita","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narikazu","family":"Boku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masao","family":"Ichinose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirofumi","family":"Yasui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,9,11]]},"reference":[{"key":"540_CR1","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.ajo.2005.01.052","volume":"140","author":"E Bita","year":"2005","unstructured":"Bita E, Dominick G, Linda L, et al. Canalicular and nasolacrimal duct blockage: anocular side effect associated with the antineoplastic drug S-1. Am J Ophtalmol. 2005;140:325\u20137.","journal-title":"Am J Ophtalmol"},{"key":"540_CR2","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S1470-2045(08)70035-4","volume":"9","author":"W Koizumi","year":"2007","unstructured":"Koizumi W, Narahara H, Hara T, et al. S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial. Lancet Oncol. 2007;9:215\u201321.","journal-title":"Lancet Oncol"},{"key":"540_CR3","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s10120-011-0009-5","volume":"14","author":"H Narahara","year":"2011","unstructured":"Narahara H, Iishi H, Imamura H, et al. Randomized phase III study comparing the efficacy and safety of irinotecan plus S-1 with S-1 alone as first-line treatment for advanced gastric cancer (study GC0301\/TOP-002). Gastric Cancer. 2011;14:72\u201380.","journal-title":"Gastric Cancer"},{"key":"540_CR4","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/S1470-2045(09)70259-1","volume":"10","author":"N Boku","year":"2009","unstructured":"Boku N, Yamamoto S, Fukuda H, et al. Fluorouracil versus combination of irinotecan plus cisplatin versus S-1 in metastatic gastric cancer: a randomised phase 3 study. Lancet Oncol. 2009;10:1063\u20139.","journal-title":"Lancet Oncol"},{"key":"540_CR5","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1056\/NEJMoa072252","volume":"357","author":"S Sakuramoto","year":"2007","unstructured":"Sakuramoto S, Sasako M, Yamaguchi T, et al. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med. 2007;357:1810\u201320.","journal-title":"N Engl J Med"},{"key":"540_CR6","doi-asserted-by":"crossref","first-page":"150","DOI":"10.2995\/jacsurg.33.150","volume":"33","author":"T Kanazawa","year":"2008","unstructured":"Kanazawa T, Tanakaya K, Takeuchi H, et al. Two cases of lacrimal duct occlusion caused by S-1 therapy in patients with gastrointestinal cancer. J Jpn Coll Surg. 2008;33:150\u20134.","journal-title":"J Jpn Coll Surg"},{"key":"540_CR7","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1034\/j.1600-0420.2000.078001110.x","volume":"78","author":"S Prasad","year":"2000","unstructured":"Prasad S, Kamath GG, Phillips RP. Lacrimal canalicular stenosis associated with systemic 5-fluorouacil therapy. Acta Ophthalmol Scand. 2000;78:110\u20133.","journal-title":"Acta Ophthalmol Scand"},{"key":"540_CR8","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/01.IOP.0000066648.33513.3D","volume":"19","author":"AS Eiseman","year":"2003","unstructured":"Eiseman AS, Flanagan JC, Brooks AB, et al. Ocular surface, ocular adnexal, and lacrimal complications associated with the use of systemic 5-fluorouracil. Ophthal Plast Reconstr Surg. 2003;19:216\u201324.","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"540_CR9","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1093\/annonc\/mds106","volume":"23","author":"N Kim","year":"2012","unstructured":"Kim N, Park C, Park DJ, et al. Lacrimal drainage obstruction in gastric cancer patients receiving S-1 chemotherapy. Ann Oncol. 2012;23:2065\u201371.","journal-title":"Ann Oncol"},{"key":"540_CR10","doi-asserted-by":"crossref","first-page":"890","DOI":"10.3341\/jkos.2010.51.6.890","volume":"51","author":"J-S Park","year":"2010","unstructured":"Park J-S, Ha SW, Lew H. Two cases of lacrimal drainage obstruction associated with S-1 anticancer treatment. J Korean Ophthalmol Soc. 2010;51:890\u20134.","journal-title":"J Korean Ophthalmol Soc"},{"key":"540_CR11","first-page":"259","volume":"38","author":"H Kitamura","year":"2011","unstructured":"Kitamura H, Miyanaga T, Shin H, et al. Investigation of epiphora following S-1 therapy. Jpn J Cancer Chemother. 2011;38:259\u201362.","journal-title":"Jpn J Cancer Chemother"},{"key":"540_CR12","first-page":"1499","volume":"63","author":"K Shioda","year":"2009","unstructured":"Shioda K, Tanabe K, Kimura S, et al. Treatment of severe canalicular blockage secondary to peroral TS-1. Jan J Clin Ophthalmol. 2009;63:1499\u2013502.","journal-title":"Jan J Clin Ophthalmol"},{"key":"540_CR13","first-page":"1639","volume":"37","author":"H Kashiwagi","year":"2010","unstructured":"Kashiwagi H. Ocular disorders of anticancer drugs\u2014ocular side effects. Jpn J Cancer Chemother. 2010;37:1639\u201344.","journal-title":"Jpn J Cancer Chemother"},{"key":"540_CR14","first-page":"271","volume":"66","author":"J Sakai","year":"2012","unstructured":"Sakai J, Inoue Y, Kashiwagi H, et al. Multi-institutional survey on the lacrimal side effects of TS-1. Jan J Clin Ophthalmol. 2012;66:271\u20134.","journal-title":"Jan J Clin Ophthalmol"},{"key":"540_CR15","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1007\/s10384-012-0127-6","volume":"56","author":"T Sasaki","year":"2012","unstructured":"Sasaki T, Miyashita H, Miyanaga T, et al. Dacryoendoscopic observation and incidence of canalicular obstruction\/stenosis associated with S-1, an oral anticancerdrug. Jpn J Ophthalmol. 2012;56:214\u20138.","journal-title":"Jpn J Ophthalmol"},{"key":"540_CR16","first-page":"919","volume":"110","author":"S Ito","year":"2006","unstructured":"Ito S, Tanaka A. Three cases of corneal disorders associated with an oral anticancer drug S-1. Nippon Ganka Gakkai Zasshi. 2006;110:919\u201323.","journal-title":"Nippon Ganka Gakkai Zasshi"},{"key":"540_CR17","first-page":"1735","volume":"37","author":"H Shibahara","year":"2010","unstructured":"Shibahara H, Kuze S, Kyokane T, et al. Optic lesions in patients with epiphora during S-1 therapy. Jpn J Cancer Chemother. 2010;37:1735\u20139.","journal-title":"Jpn J Cancer Chemother"},{"key":"540_CR18","first-page":"915","volume":"30","author":"H Kashiwagi","year":"2013","unstructured":"Kashiwagi H. Lacrimal drainage obstruction and stenosis associated with anti-cancer drug S-1. J Eye. 2013;30:915\u201321.","journal-title":"J Eye"}],"container-title":["Gastric Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10120-015-0540-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10120-015-0540-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10120-015-0540-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,30]],"date-time":"2019-08-30T10:59:38Z","timestamp":1567162778000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10120-015-0540-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,11]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["540"],"URL":"https:\/\/doi.org\/10.1007\/s10120-015-0540-x","relation":{},"ISSN":["1436-3291","1436-3305"],"issn-type":[{"value":"1436-3291","type":"print"},{"value":"1436-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,11]]}}}